Advitech seeks US distributor as PhotoMedex deal falls through

By staff reporter

- Last updated on GMT

Related tags: License, Advitech

Advitech has reopened negotiations for the US distribution of its
Dermylex psoriasis supplement, after the withdrawal of its
agreement in principle with PhotoMedex.

Advitech entered into the agreement in January 2006, but it has not culminated in a definitive agreement because PhotoMedex was unable to meet the conditions. It has not specified what conditions these were.

Test markets are already running in the US, and negotiations are underway with other potential partners, with a view to securing a definitive agreement by first quarter 2007.

The Canadian company has also engaged the services of Joe Contorno, formerly of Doctor's Dermatological Formula, to assist in the discussions and follow market developments.

Definitive agreements are already in place in Canada and France, with Jamieson Laboratories and Cothera respectively, and an agreement in principle for Taiwan with Enbio-Life Biotechnology & Medical Co.

Advitech pays royalties on international sales of the sweet-whey derived nutraceutical to Jouan Biotechnologies. Following the conclusion of the initial three-year agreement, the company has negotiated a new agreement until 2013 with a reduced royalty fee percentage.

There is also the possibility of a license agreement extension until the expiry of the last foreign patent to the underlying technology.

Related news

Show more

Related products

show more

Making Health Claims on Infant Nutrition

Making Health Claims on Infant Nutrition

KGK Science, Inc. | 09-Jul-2018 | Technical / White Paper

The market for infant formula has expanded over the past decade and competition is high amongst leading manufacturers to make claims that differentiate...

UAS Labs Announces New Fermentation Facility

UAS Labs Announces New Fermentation Facility

UAS Laboratories | 04-May-2018 | Product Presentation

UAS Labs’ new fermentation facility is changing the strain game! The facility sets new standards for probiotic manufacturing in terms of quality, purity...

Discover The DDS®-1 Difference

Discover The DDS®-1 Difference

UAS Laboratories | 18-Apr-2018 | Technical / White Paper

The DDS®-1 strain of Lactobacillus acidophilus has been shown, either alone or in combination, to alleviate symptoms of lactose intolerance and Irritable...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars